| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.049 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |